Mythocondro® is the first Non-Animal Chondroitin Sulfate (CS) obtained through a fermentation-based manufacturing process providing a reliable and reproducible source of product. Mythocondro® solves any concerns related to the production origin, the possible presence of transmissible infective agents, the contaminations and adulterations typical of animal-derived raw materials and promises to completely change the global CS industry.
Mythocondro® warrants high purity, clear identity profile, batch-to-batch reproducibility, established safety and very low content of proteins and other (macro)molecules, as well as biological activity.
Mythocondro® is clinically tested, well characterized and environmentally friendly; it is the first CS suitable for vegetarians and free from restrictions of use related to religious and supply issues.
Mythocondro® has been developed using a pharmaceutical development approach, and is the result of years of research that generated five international patents.
Mythocondro® addresses the growing demand from an aging population suffering from a variety of degenerative joint conditions that may benefit from an effective and safe nutritional supplement that supports strong and healthy joints.
Mythocondro® resolves the long-standing acknowledged problem of poor quality and potential safety issues of animal-derived CS with significant effectiveness in joint disease.